Navigating the Atopic Dermatitis Treatment Landscape: Personalized Treatment Approaches to Systemic Therapy
Tiffany Mayo, MD, FAAD, discusses how to personalize systemic treatment approaches for atopic dermatitis by considering patient-specific factors, including age, comorbidities, disease impact, lifestyle preferences, and the importance of shared decision-making when selecting between biologics and JAK inhibitors.
EP. 1: The Clinical Impact of Atopic Dermatitis: Burden, Age-Related Differences, and Unmet Needs
June 26th 2025An expert discusses how atopic dermatitis creates significant physical and quality-of-life burdens affecting up to 20% of pediatric and 10% of adult patients globally, with presentations varying across age groups and key unmet needs including improved access to care and disease recognition across different skin tones.
EP. 2: Approaches to Personalizing Systemic Treatment in Atopic Dermatitis
June 26th 2025An expert discusses how personalizing systemic atopic dermatitis treatment requires considering factors such as disease severity, patient impact, treatment failures, age, comorbidities, and patient preferences when selecting between biologics and JAK inhibitors.
EP. 3: Escalating to Biologic Therapy in a 5-Year-Old With Severe Atopic Dermatitis
July 7th 2025An expert discusses how a 5-year-old child with severe atopic dermatitis affecting sleep and school performance demonstrates the need for systemic therapy escalation, with dupilumab being an ideal choice given its efficacy for both atopic dermatitis and comorbid asthma.
